Gotham Asset Management LLC Makes New $325,000 Investment in Indivior PLC (NASDAQ:INDV)

Gotham Asset Management LLC purchased a new position in Indivior PLC (NASDAQ:INDV - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 26,121 shares of the company's stock, valued at approximately $325,000.

A number of other hedge funds also recently bought and sold shares of INDV. China Universal Asset Management Co. Ltd. purchased a new stake in Indivior during the 4th quarter valued at $359,000. VELA Investment Management LLC lifted its holdings in shares of Indivior by 45.5% during the fourth quarter. VELA Investment Management LLC now owns 179,659 shares of the company's stock valued at $2,264,000 after purchasing an additional 56,224 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Indivior during the fourth quarter valued at $56,000. Kazazian Asset Management LLC bought a new stake in Indivior in the 4th quarter worth about $1,706,000. Finally, Melqart Asset Management UK Ltd raised its position in Indivior by 675.6% in the 4th quarter. Melqart Asset Management UK Ltd now owns 104,790 shares of the company's stock worth $1,303,000 after buying an additional 91,280 shares during the last quarter. Institutional investors own 60.33% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on INDV shares. Piper Sandler dropped their price target on shares of Indivior from $16.00 to $13.00 and set an "overweight" rating on the stock in a report on Thursday, March 6th. RODMAN&RENSHAW upgraded shares of Indivior to a "strong-buy" rating in a research report on Tuesday, January 28th. Finally, Rodman & Renshaw began coverage on shares of Indivior in a report on Tuesday, January 28th. They issued a "buy" rating and a $16.00 target price on the stock.

Indivior Trading Up 0.4%

INDV stock traded up $0.05 during trading on Monday, reaching $11.26. The stock had a trading volume of 1,303,351 shares, compared to its average volume of 1,022,970. The firm has a market cap of $1.55 billion, a PE ratio of -32.17 and a beta of 0.98. The stock's 50 day moving average is $10.30 and its two-hundred day moving average is $10.71. Indivior PLC has a 52 week low of $7.33 and a 52 week high of $18.59.

Indivior (NASDAQ:INDV - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.22 by $0.19. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. The firm had revenue of $266.00 million during the quarter, compared to analyst estimates of $240.13 million. On average, research analysts anticipate that Indivior PLC will post 1.22 EPS for the current year.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.